IRLA
Irulya Therapeutics
$31.62
−$1.33 (−4.05%)Oct 29, 2026
Key metrics
The numbers that frame IRLA today
- Market cap
- $32.16M
- ROIC
- -1,714.5%
- Div yield
- 0%
- 52wk Low
- $15.10
- 52wk High
- $909.98
Growth
Revenue and earnings trend for IRLA
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about IRLA
Is Irulya Therapeutics a good buy?
No. Irulya Therapeutics has poor quality and poor momentum. Both signals point to a weaker setup. Growth looks excellent, which supports the long-term business case, but that is not enough to offset the weak setup.
What is the market capitalization of IRLA?
Irulya Therapeutics's market capitalization is $32.16M.
What is the 52-week high for IRLA stock?
The 52-week high for Irulya Therapeutics is $909.98. The current close of $31.62 is 96.5% below that high.
What is the 52-week low for IRLA stock?
The 52-week low for Irulya Therapeutics is $15.10. The current close of $31.62 is 109.4% above that low.
Does IRLA stock pay dividends?
Irulya Therapeutics does not currently show a dividend per share in the company data.